" /> Ozanimod - CISMeF





Preferred Label : Ozanimod;

NCIt definition : An orally bioavailable sphingosine-1-phosphate (S1P) receptors 1 (S1PR1, S1P1) and 5 (S1PR5, S1P5) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, ozanimod selectively targets and binds to S1PR1 on lymphocytes and induces S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes, ozanimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. Modulation of S1PR5 by ozanimod may be neuroprotective.;

UNII : Z80293URPV;

InChIKey : XRVDGNKRPOAQTN-FQEVSTJZSA-N;

CAS number : 1306760-87-1;

Molecule name : RPC-1063; RPC 1063;

NCI Metathesaurus CUI : CL1382523;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.